D. W. Bell

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

Patricia L. Harris, D. Louis, D. Christiani, 2004, The New England journal of medicine.

Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor.

A. Feinberg, K. Broman, D. Haber, 2001, Journal of the National Cancer Institute.